Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

RCUSRCUS
6 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in Arcus Biosciences, Inc.

WELLINGTON MANAGEMENT GROUP LLP holds 5.9M shares of RCUS (Arcus Biosciences, Inc.), worth $181.8M as of 2026-Q2. The position was decreased (-3.2% shares). RCUS represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$181.8M

Current Shares

5.9M

Total Value Change

+$173.3M

Total Shares Change

+4.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.9M
-3.2%
$181.8M0.0%$30.83
0
2026-Q1
Increased
6.1M
+17.5%
$131.5M0.0%$22.43
35
2025-Q4
Increased
5.2M
+309.4%
$123.5M0.0%$23.23
49
2025-Q3
Increased
1.3M
+35.3%
$17.2M0.0%$13.32
37
2025-Q2
Decreased
936,021
-13.6%
$7.6M0.0%$7.95
0
2025-Q1
New
1.1M
-
$8.5M0.0%$8.17
38

Other major holders of RCUS: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used